NZ592705A - 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication - Google Patents
4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replicationInfo
- Publication number
- NZ592705A NZ592705A NZ592705A NZ59270509A NZ592705A NZ 592705 A NZ592705 A NZ 592705A NZ 592705 A NZ592705 A NZ 592705A NZ 59270509 A NZ59270509 A NZ 59270509A NZ 592705 A NZ592705 A NZ 592705A
- Authority
- NZ
- New Zealand
- Prior art keywords
- amino
- oxobutanoyl
- peptide cyclic
- oxobutanoyl peptide
- cyclic analogues
- Prior art date
Links
- -1 4-amino-4-oxobutanoyl Chemical group 0.000 title abstract 6
- 125000004122 cyclic group Chemical group 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 230000029812 viral genome replication Effects 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 241000711549 Hepacivirus C Species 0.000 abstract 1
- 208000005176 Hepatitis C Diseases 0.000 abstract 1
- 229940124639 Selective inhibitor Drugs 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 208000010710 hepatitis C virus infection Diseases 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12137808P | 2008-12-10 | 2008-12-10 | |
| US22632309P | 2009-07-17 | 2009-07-17 | |
| PCT/US2009/067507 WO2010068761A2 (en) | 2008-12-10 | 2009-12-10 | 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ592705A true NZ592705A (en) | 2013-02-22 |
Family
ID=42241240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ592705A NZ592705A (en) | 2008-12-10 | 2009-12-10 | 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20100152103A1 (enExample) |
| EP (1) | EP2364310B1 (enExample) |
| JP (1) | JP5669749B2 (enExample) |
| KR (1) | KR20110096557A (enExample) |
| CN (1) | CN102245598B (enExample) |
| AU (1) | AU2009324644B2 (enExample) |
| BR (1) | BRPI0922913A2 (enExample) |
| CA (1) | CA2746265A1 (enExample) |
| EA (1) | EA021794B1 (enExample) |
| IL (1) | IL212787A0 (enExample) |
| MX (1) | MX2011006239A (enExample) |
| NZ (1) | NZ592705A (enExample) |
| WO (1) | WO2010068761A2 (enExample) |
| ZA (1) | ZA201104383B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009142842A2 (en) | 2008-04-15 | 2009-11-26 | Intermune, Inc. | Novel macrocyclic inhibitors of hepatitis c virus replication |
| AU2009303483A1 (en) * | 2008-10-15 | 2010-04-22 | Intermune, Inc. | Therapeutic antiviral peptides |
| AR075584A1 (es) * | 2009-02-27 | 2011-04-20 | Intermune Inc | COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO. |
| US8835456B1 (en) | 2011-03-18 | 2014-09-16 | Achillion Pharmaceuticals, Inc. | NS5A inhibitors useful for treating HCV |
| US8957203B2 (en) | 2011-05-05 | 2015-02-17 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| PH12013502455A1 (en) | 2011-05-27 | 2014-01-20 | Achillion Pharmaceuticals Inc | Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections |
| UA119315C2 (uk) | 2012-07-03 | 2019-06-10 | Гіліад Фармассет Елелсі | Інгібітори вірусу гепатиту с |
| HRP20161694T1 (hr) | 2012-10-19 | 2017-03-10 | Bristol-Myers Squibb Company | 9-metil supstituirani heksadekahidrociklopropa(e)pirolo (1,2-a)(1,4) diazaciklopentadecinil karbamat derivati kao ne-strukturalni 3 (ns3) proteazni inhibitori za liječenje infekcija virusom hepatitisa c |
| WO2014070964A1 (en) | 2012-11-02 | 2014-05-08 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
| US9643999B2 (en) | 2012-11-02 | 2017-05-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| EP2914598B1 (en) | 2012-11-02 | 2017-10-18 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
| US9409943B2 (en) | 2012-11-05 | 2016-08-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US9580463B2 (en) | 2013-03-07 | 2017-02-28 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| SG11201508431VA (en) | 2013-03-13 | 2015-11-27 | Harvard College | Stapled and stitched polypeptides and uses thereof |
| US9085607B2 (en) * | 2013-03-15 | 2015-07-21 | Achillion Pharmaceuticals, Inc. | ACH-0142684 sodium salt polymorph, composition including the same, and method of manufacture thereof |
| ES2735355T3 (es) | 2013-03-15 | 2019-12-18 | Gilead Sciences Inc | Inhibidores macrocíclicos y bicíclicos de virus de hepatitis C |
| WO2014145507A1 (en) | 2013-03-15 | 2014-09-18 | Achillion Pharmaceuticals, Inc. | A process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof |
| CA2909270A1 (en) | 2013-04-12 | 2014-10-16 | Achillion Pharmaceuticals, Inc. | Highly active nucleoside derivative for the treatment of hcv |
| EP3008081B1 (en) | 2013-06-14 | 2017-08-30 | President and Fellows of Harvard College | Stabilized polypeptide insulin receptor modulators |
| US10533039B2 (en) | 2014-05-21 | 2020-01-14 | President And Fellows Of Harvard College | Ras inhibitory peptides and uses thereof |
| MX2020002435A (es) | 2017-09-07 | 2020-09-22 | Fog Pharmaceuticals Inc | Agentes que modulan las funciones de beta-catenina y sus métodos. |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA74546C2 (en) * | 1999-04-06 | 2006-01-16 | Boehringer Ingelheim Ca Ltd | Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition |
| US6608027B1 (en) * | 1999-04-06 | 2003-08-19 | Boehringer Ingelheim (Canada) Ltd | Macrocyclic peptides active against the hepatitis C virus |
| CN100391967C (zh) * | 2000-11-20 | 2008-06-04 | 布里斯托尔-迈尔斯斯奎布公司 | 丙型肝炎三肽抑制剂 |
| US6867185B2 (en) * | 2001-12-20 | 2005-03-15 | Bristol-Myers Squibb Company | Inhibitors of hepatitis C virus |
| US7119072B2 (en) * | 2002-01-30 | 2006-10-10 | Boehringer Ingelheim (Canada) Ltd. | Macrocyclic peptides active against the hepatitis C virus |
| WO2004043339A2 (en) * | 2002-05-20 | 2004-05-27 | Bristol-Myers Squibb Company | Substituted cycloalkyl p1' hepatitis c virus inhibitors |
| US20060199773A1 (en) * | 2002-05-20 | 2006-09-07 | Sausker Justin B | Crystalline forms of (1R,2S)-N-[(1,1-dimethylethoxy)carbonyl]-3-methyl-L-valyl-(4R)-4-[(6-methoxy-1-isoquinolinyl)oxy]-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenyl-cyclopropanecarboxamide, monopotassium salt |
| DE60336550D1 (de) * | 2002-05-20 | 2011-05-12 | Bristol Myers Squibb Co | Inhibitoren des hepatitis-c-virus |
| MY140680A (en) * | 2002-05-20 | 2010-01-15 | Bristol Myers Squibb Co | Hepatitis c virus inhibitors |
| US7601709B2 (en) * | 2003-02-07 | 2009-10-13 | Enanta Pharmaceuticals, Inc. | Macrocyclic hepatitis C serine protease inhibitors |
| WO2004072243A2 (en) * | 2003-02-07 | 2004-08-26 | Enanta Pharmaceuticals, Inc. | Macrocyclic hepatitis c serine protease inhibitors |
| US20040180815A1 (en) * | 2003-03-07 | 2004-09-16 | Suanne Nakajima | Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors |
| CA2516018C (en) * | 2003-03-05 | 2011-08-23 | Boehringer Ingelheim International Gmbh | Hepatitis c inhibitor peptide analogs |
| US7176208B2 (en) * | 2003-04-18 | 2007-02-13 | Enanta Pharmaceuticals, Inc. | Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| UY29016A1 (es) * | 2004-07-20 | 2006-02-24 | Boehringer Ingelheim Int | Analogos de dipeptidos inhibidores de la hepatitis c |
| JP4914355B2 (ja) * | 2004-07-20 | 2012-04-11 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃ型肝炎インヒビターペプチド類似体 |
| US7153848B2 (en) * | 2004-08-09 | 2006-12-26 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
| CN101039947A (zh) * | 2004-08-09 | 2007-09-19 | 布里斯托尔-迈尔斯斯奎布公司 | Hcv复制抑制剂 |
| US7659263B2 (en) * | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
| US7601686B2 (en) * | 2005-07-11 | 2009-10-13 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7772183B2 (en) * | 2005-10-12 | 2010-08-10 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7741281B2 (en) * | 2005-11-03 | 2010-06-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| EP2041156B1 (en) * | 2006-07-13 | 2013-11-20 | Achillion Pharmaceuticals, Inc. | 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| WO2010068760A2 (en) * | 2008-12-10 | 2010-06-17 | Achillion Pharmaceuticals, Inc. | New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
-
2009
- 2009-12-10 US US12/635,049 patent/US20100152103A1/en active Granted
- 2009-12-10 MX MX2011006239A patent/MX2011006239A/es active IP Right Grant
- 2009-12-10 JP JP2011540890A patent/JP5669749B2/ja not_active Expired - Fee Related
- 2009-12-10 BR BRPI0922913-2A patent/BRPI0922913A2/pt not_active IP Right Cessation
- 2009-12-10 CN CN200980149521.0A patent/CN102245598B/zh not_active Expired - Fee Related
- 2009-12-10 CA CA2746265A patent/CA2746265A1/en not_active Abandoned
- 2009-12-10 EP EP09832542.6A patent/EP2364310B1/en not_active Not-in-force
- 2009-12-10 WO PCT/US2009/067507 patent/WO2010068761A2/en not_active Ceased
- 2009-12-10 AU AU2009324644A patent/AU2009324644B2/en not_active Ceased
- 2009-12-10 NZ NZ592705A patent/NZ592705A/xx not_active IP Right Cessation
- 2009-12-10 EA EA201100927A patent/EA021794B1/ru not_active IP Right Cessation
- 2009-12-10 KR KR1020117015042A patent/KR20110096557A/ko not_active Ceased
-
2011
- 2011-05-09 IL IL212787A patent/IL212787A0/en unknown
- 2011-06-13 ZA ZA2011/04383A patent/ZA201104383B/en unknown
-
2014
- 2014-03-24 US US14/223,480 patent/US20140206604A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2011006239A (es) | 2011-06-28 |
| CN102245598A (zh) | 2011-11-16 |
| IL212787A0 (en) | 2011-07-31 |
| CA2746265A1 (en) | 2010-06-17 |
| WO2010068761A2 (en) | 2010-06-17 |
| BRPI0922913A2 (pt) | 2015-08-18 |
| JP5669749B2 (ja) | 2015-02-12 |
| US20140206604A1 (en) | 2014-07-24 |
| EP2364310A4 (en) | 2012-05-16 |
| EA201100927A1 (ru) | 2011-12-30 |
| EP2364310B1 (en) | 2015-07-29 |
| AU2009324644A1 (en) | 2010-06-17 |
| ZA201104383B (en) | 2012-03-28 |
| KR20110096557A (ko) | 2011-08-30 |
| WO2010068761A3 (en) | 2010-10-21 |
| AU2009324644B2 (en) | 2013-12-05 |
| EA021794B1 (ru) | 2015-09-30 |
| JP2012511588A (ja) | 2012-05-24 |
| CN102245598B (zh) | 2014-01-29 |
| EP2364310A2 (en) | 2011-09-14 |
| US20100152103A1 (en) | 2010-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ592705A (en) | 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication | |
| PH12012501881A1 (en) | 4-amino-4- oxobutanoyl peptides as inhibitors of viral replication | |
| WO2010068760A3 (en) | New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication | |
| WO2009042668A3 (en) | Urea-containing peptides as inhibitors of viral replication | |
| MX2010006210A (es) | Inhibidores de serina proteasa de hcv de tripeptido fluorado. | |
| MX2018015315A (es) | Agentes antivirales contra la hepatitis b. | |
| WO2005007681A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| IL207468A (en) | HCV inhibitors and their use in the preparation of medicines for the treatment of HCV infections | |
| TW200510391A (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | |
| MY160130A (en) | Hepatitis c virus inhibitors | |
| WO2010084115A3 (en) | Antiviral agents | |
| MX2010005262A (es) | Compuestos que contienen quinoxalina como inhibidores del virus de hepatitis c. | |
| PH12020550065A1 (en) | Hepatitis b antiviral agents | |
| IL182315A0 (en) | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection | |
| ATE413411T1 (de) | Substituierte cycloalkyl p1' hepatitis c virus inhibitoren | |
| MX2010010276A (es) | Compuestos macrociclicos fluorinados como inhibidores del virus de hepatitis c. | |
| NO20072689L (no) | Tetrasykliske indolderivater som antivirale midler | |
| MXPA06000418A (es) | Derivados de ariltiourea sustituida utiles como inhibidores de duplicacion viral. | |
| WO2009076166A3 (en) | Oximyl hcv serine protease inhibitors | |
| EA200970805A1 (ru) | Ингибиторы серинпротеаз для лечения hcv инфекций | |
| TN2011000258A1 (en) | Pharmaceutical composition of a potent hcv inhibitor for oral administration | |
| BRPI0511283A (pt) | aril aciltiouréias substituìdas e compostos relacionados; inibidores da replicação viral | |
| BR112013028679A2 (pt) | inibidores do vírus da hepatite c | |
| MX2010008108A (es) | Inhibidores de proteasa de serina de tripéptido de virus de hepatitis c (hcv) que contienen heteroarilo. | |
| UA101468C2 (ru) | 4-амино-4-оксобутаноиловые пептиды как ингибиторы вирусной репликации |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ERR | Error or correction |
Free format text: THE TITLE HAS BEEN CORRECTED TO TITLE: 4-AMINO-4-OXOBUTANOYL PEPTIDE CYCLIC ANALOGUES, INHIBITORS OF VIRAL REPLICATION; FILING DATE: 09 MAY 2011; STATUS: REJECTED; TITLE: 4-AMINO-4-OXOBUTANOYL PEPTIDE CYCLIC ANALOGUES, INHIBITORS OF VIRAL REPLICATION; FILING DATE: 06 NOV 2012; STATUS: REJECTED; TITLE: 4-AMINO-4-OXOBUTANOYL PEPTIDE CYCLIC ANALOGUES, INHIBITORS OF VIRAL REPLICATION; FILING DATE: 02 APR 2012; STATUS: REJECTED; TITLE: 4-AMINO-4-OXOBUTANOYL PEPTIDE CYCLIC ANALOGUES, INHIBITORS OF VIRAL REPLICATION; FILING DATE: 31 JUL 2012; STATUS: REJECTED; TITLE: 4-AMINO-4-OXOBUTANOYL PEPTIDE CYCLIC ANALOGUES, INHIBITORS OF VIRAL REPLICATION; FILING DATE: 05 FEB 2013; STATUS: SUPERSEDED; PUBLIC Effective date: 20130417 Free format text: THE TITLE HAS BEEN CORRECTED TO TITLE: 4-AMINO-4-OXOBUTANOYL PEPTIDE CYCLIC ANALOGUES, INHIBITORS OF VIRAL REPLICATION; FILING DATE: 09 MAY 2011; STATUS: REJECTED; TITLE: 4-AMINO-4-OXOBUTANOYL PEPTIDE CYCLIC ANALOGUES, INHIBITORS OF VIRAL REPLICATION; FILING DATE: 06 NOV 2012; STATUS: REJECTED; TITLE: 4-AMINO-4-OXOBUTANOYL PEPTIDE CYCLIC ANALOGUES, INHIBITORS OF VIRAL REPLICATION; FILING DATE: 02 APR 2012; STATUS: REJECTED; TITLE: 4-AMINO-4-OXOBUTANOYL PEPTIDE CYCLIC ANALOGUES, INHIBITORS OF VIRAL REPLICATION; FILING DATE: 31 JUL 2012; STATUS: REJECTED; TITLE: 4-AMINO-4-OXOBUTANOYL PEPTIDE CYCLIC ANALOGUES, INHIBITORS OF VIRAL REPLICATION; FILING DATE: 05 FEB 2013; STATUS: SUPERSEDED; PUBLIC Effective date: 20130418 |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 10 DEC 2016 BY CULLENS Effective date: 20150304 |
|
| LAPS | Patent lapsed |